Lumexa Imaging names Kyle Lynch as chief growth officer

Lumexa Imaging (NASDAQ: LMRI) appointed Kyle Lynch as chief growth officer, the outpatient imaging services provider announced April 20. Lynch will lead the company's growth strategy, including joint ventures, acquisitions and new location development.

In his role, Lynch will oversee growth initiatives from opportunity identification through transaction execution and integration. He will work with senior leadership to align expansion efforts with operational and financial objectives.

"Kyle brings a powerful combination of strategic insight, execution discipline, and commercial leadership," said Caitlin Zulla, chief executive officer of Lumexa Imaging.

Lynch will also lead the company's Sales Center of Excellence, focusing on sales productivity, performance metrics and referral growth across Lumexa Imaging's locations.

Before joining Lumexa Imaging, Lynch served as senior vice president of strategy and development at SCA Health, where he led growth initiatives across a national healthcare services platform.

Lumexa Imaging operates more than 185 outpatient imaging centers across 13 states with over 5,000 employees. The company conducted approximately 4 million outpatient procedures in 2025, according to the press release.

You May Also Be Interested In

• Circle board member resigns after nearly 13 years of service
• Venu Holding enters $250 million at-the-market stock offering agreement
• Starbucks designates Val Bauduin as principal accounting officer